Rituxan deaths reported to FDA
James G. Dickinson
February 01 2007
The deaths of two women being treated with Genentech’s Rituxan (rituximab) for systemic lupus erythematosus have been reported to the ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.